In addition, it was demonstrated that the downregulation of DNMT1 activated a methylated MAGEA1 transgene in melanoma cells, strengthening the theory that DNA methylation is the primary mode of expression regulation for CTAs [202]. The gene discussed is MAGEA1; the disease is melanoma.